Sam Watson Archives | Page 3 of 4 | Cannabiz

Cannabis executive salaries: who earned what in FY24

by Steve Jones October 16, 2024October 15, 2025

While the majority of Australia’s ASX-listed cannabis firms saw revenues climb in FY24, profitability often remained […]

Bioxyne forecasts doubling of revenue amid ‘$100m gummy opportunity’

by Steve Jones September 26, 2024September 26, 2024

BLS delivers first gummies manufactured under GMP licence

by Martin Lane August 21, 2024January 13, 2025

Company news: Avecho; Bioxyne; Elixinol Wellness; IDT Australia; Melodiol Global Health; Zelira

by Steve Jones July 31, 2024November 25, 2024

Financial results: Bioxyne; Melodiol Global Health; Emyria; Zelira; Elixinol; Wellnex Life; Argent BioPharma

by Steve Jones May 1, 2024May 1, 2024

Company news: Bioxyne/BLS; Rua Bioscience; Botanix; Melodiol Global Health; Zelira; Argent BioPharma

by Martin Lane and Steve Jones April 16, 2024July 16, 2024

Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth

by Steve Jones March 7, 2024March 7, 2024

Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience

by Steve Jones and Martin Lane February 7, 2024November 25, 2024

BLS launches B2B trading platform CanxChange with $10m sales pipeline in week one

by Martin Lane January 22, 2024July 11, 2024

Company news: Breathe Life Sciences; Cann Group; InhaleRx; X-Hemp; Green Farmers/Elevated Signals

by Martin Lane October 19, 2023April 30, 2024